Paris - Delayed Quote EUR
MaaT Pharma SA (MAAT.PA)
5.82
-0.10
(-1.69%)
At close: 5:29:59 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-22,041
-22,041
-18,670
-12,605
-7,929
Investing Cash Flow
-416
-416
-440
-815
-238
Financing Cash Flow
18,331
18,331
8,141
5,364
31,558
End Cash Position
20,154
20,154
24,280
35,247
43,304
Capital Expenditure
-753
-753
-1,093
-662
-238
Issuance of Capital Stock
17,276
17,276
12,592
102
32,435
Issuance of Debt
5,117
5,117
--
7,476
462
Repayment of Debt
-3,576
-3,576
-4,193
-1,926
-947
Repurchase of Capital Stock
--
--
-79
-137
--
Free Cash Flow
-22,794
-22,794
-19,763
-13,267
-8,167
12/31/2021 - 7/21/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SYBX Synlogic, Inc.
1.1600
+3.57%
ABVX.PA ABIVAX Société Anonyme
6.12
+1.32%
PHGE BiomX Inc.
0.6149
+4.04%
SEPN Septerna, Inc.
6.46
+5.21%
IDIA.SW Idorsia Ltd
1.1460
-1.04%
SPRB Spruce Biosciences, Inc.
0.1399
+5.27%
VTYX Ventyx Biosciences, Inc.
1.2600
+8.62%
PHAT Phathom Pharmaceuticals, Inc.
4.1200
+2.49%
JANX Janux Therapeutics, Inc.
32.07
+1.42%
UNCY Unicycive Therapeutics, Inc.
0.6400
+0.91%